The New York Times publishes UB scientist's op-ed about caffeinated energy drinks

An opinion piece in The New York Times by Kathleen
Miller, senior research scientist at UB’s Research Institute
on Addictions, about the decision by CVS to stop selling tobacco
products suggests the drug store chain should also consider
discontinuing sales of caffeinated energy drinks to kids under the
age of 18. “Because caffeine is widely used and generally
considered safe in moderate doses, we too often forget it is a
psychoactive drug – and potentially dangerous in larger
amounts, particularly for children,” she writes.